ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "chemotherapy"
chemotherapy
Osoba
Předměty
Osoby
Publikace
Studium
Exportovat aktuální pohled
MUDr. Ondřej Šorejs Ph.D.
Externí osoba na Lékařská fakulta v Plzni
22 publikací
Publikace
publication
Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction
2023 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience
2023 |
Lékařská fakulta v Plzni
publication
Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer
2020 |
Lékařská fakulta v Plzni
publication
The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents
2019 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
2018 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed
2017 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab
2017 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
Imunoterapie v léčbě karcinomu plic
2017 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy
2016 |
Lékařská fakulta v Plzni, 1. lékařská fakulta
publication
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate
2024 |
Lékařská fakulta v Plzni
Načíst další publikace (12)
Loading network view...